A study of NPY-mediated contractions of the porcine isolated ear artery

British Journal of Pharmacology

Volumn 127, Issue 1, 1999, Pages 284-290

  Roberts, R E ^a   Kendall, D A ^a   Wilson, V G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

2 adrenoceptors; Cyclic AMP; Neuropeptide Y; Porcine ear artery; Sodium nitroprusside; UK14304; Vasoconstriction

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; BUCLADESINE; CYCLIC AMP; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; NEUROPEPTIDE Y; NITROPRUSSIDE SODIUM;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; EAR ARTERY; NONHUMAN; PRIORITY JOURNAL; SWINE;

ADENYLATE CYCLASE; ADRENERGIC ALPHA-AGONISTS; ANGIOTENSIN II; ANIMALS; CYCLIC AMP; EAR, EXTERNAL; FORSKOLIN; ISOMETRIC CONTRACTION; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NEUROPEPTIDE Y; NITROPRUSSIDE; QUINOXALINES; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, NEUROPEPTIDE Y; REGIONAL BLOOD FLOW; SWINE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0032938582     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702544     Document Type: Article

References (28)

1. Abel, P.W. & Han, C. (1989). Effects of neuropeptide Y on contraction, relaxation, and membrane potential of rabbit cerebral arteries. J. Cardiovasc. Pharmacol., 13, 52-63.
2. 2-adrenergic receptor-mediated contraction of vascular smooth muscle. Circ. Res., 72, 778-785.
3. Balasubramaniam, A. (1997). Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides, 18, 445-457.
4. Bylund, D.B.,Eikenburg, D.C., Hieble, J.P., Langer, S.Z., Lefkowitz, R.J., Minneman, K.P., Molinoff, P.B., Ruffolo, R.R, & Trendelenburg, U. (1994). International Union of Pharmacology nomenclature on adrenoceptors. Pharmacol. Rev., 46, 121-136.
5. Cressier, F., Criscione, L. & Hofbauer, K.G. (1995). Mechanism of interaction between neuropeptide Y and angiotensin II in the rabbit femoral artery. Eur. J. Pharmacol., 272, 57-65.
6. 2+ in cultured porcine aortic smooth muscle cells. J. Cardiovasc. Pharmacol., 22, 97-103.
7. 1-like neuropeptide Y receptors in SK-N-MC cells. Naunyn-Schmiedeberg's Arch. Pharmacol., 344, 1-7.
8. Fredholm, B.B., Jansen, I. & Edvinsson, L. (1985). Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vessels. Acta Physiol. Scand., 124, 467-469.
9. Gerald, C., Walker, M.W., Criscione, L., Gustafson, E.L., Batzl-Hartmann, C., Smith, K.E., Vaysse, P., Durkin, M.M., Laz, M., Linemeyer, D.L., Schaffhauser, A.O., Whitebread, S., Hofbauer, K.G., Taber, R.I., Branchek, T.A. & Weinshank, R.L. (1996). A receptor subtype involved in neuropeptide-Y-induced food intake. Nature, 382, 168-171.
10. Grundemar, L. & Hogestatt, E.D. (1992). Unmasking the vasoconstrictor response to neuropeptide Y and its interaction with vasodilating agents in vitro. Eur. J. Pharmacol., 221, 71-76.
11. Han, C. & Abel, P.W. (1987). Neuropeptide Y potentiates contraction and inhibits relaxation of rabbit coronary arteries. J. Cardiovasc. Pharmacol., 9, 675-681.
12. Hei, Y.-J., Macdonnell, K.L., Mcneill, J.H. & Diamond, J. (1991). Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of contraction of rat vas deferens by cyclic AMP analogs. Mol. Pharmacol., 39, 233-238.
13. 3 receptors. Eur. J. Pharmaco., 278, R3-R5.
14. 2-adrenoceptor-and (endothelium-dependent) neuropeptide Y-mediated contractions in the isolated vascular bed of the rat tail. Br. J. Pharmacol., 101, 205-211.
15. McDermott, B.J., Millar, B.C. & Piper, H.M. (1993). Cardiovascular effects of neuropeptide Y: receptor interactions and cellular mechanisms. Cardiovasc. Res., 27, 893-905.
16. 2+ increases in vascular smooth muscle cells. FEBS Lett., 259, 79-82.
17. 2 receptor of neuropeptide Y. Eur. J. Pharmacol., 327, 163-167.
18. Prieto, D., Buus, C., Mulvany, M.J. & Nilsson, H. (1997). Interactions between neuropeptide Y and the adenylate cyclase pathway in rat mesenteric small arteries: role of membrane potential. J. Physiol., 502.2, 281-292.
19. 1-like and angiotensin II-induced vasoconstriction and cyclic AMP content of the rabbit isolated femoral artery. Br. J. Pharmacol., 118, 627-634.
20. Rembold, C.M. (1992). Regulation of contraction and relaxation in arterial smooth muscle. Hypertension, 20, 129-137.
21. 2-Adrenoceptor-mediated contractions of the porcine isolated ear artery: evidence for a cyclic AMP-dependent and a cyclic AMP-independent mechanism. Br. J. Pharmacol., 124, 1107-1114.
22. 2 receptor function to changes in extracellular calcium availability and prior in vitro peptide exposure. Neuropeptides, 25, 289-298.
23. Tschopl, M., Miller, R.C., Pelton, J., Stoclet, J.-C. & Bucher, B. (1993). Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine. Br. J. Pharmacol., 110, 1098-1104.
24. Wahlestedt, C., Edvinsson, L., Ekbald, E. & Hakanson, R. (1985). Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J. Biol. Chem., 234, 735-741.
25. Wright, I.K., Blaylock, N.B., Kendall, D.A. & Wilson, V.G. (1995a). The relationship between density of α-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels. Br. J. Pharmacol., 114, 678-688.
26. Wright, I.K., Blaylock, N.B., Stark, G., Kendall, D.A. & Wilson, V.G. (1995b). Neuropeptide Y-induced modulation of cyclic adenosine monophosphate and contractile responses in porcine isolated blood vessels. J. Physiol., 483, 11IP.
27. 2-adrenoceptor mediated contractions of the porcine isolated palmar lateral vein. Br. J. Pharmacol., 114, 157-165.
28. Xia, J., Neild, T.O. & Kotecha, N. (1992). Effects of neuropeptide Y and agonists selective for neuropeptide Y receptor subtypes on arterioles of the guinea-pig small intestine and the rat brain. Br. J. Pharmacol., 107, 771-776.